Editas Medicine
EDIT
EDIT
151 hedge funds and large institutions have $934M invested in Editas Medicine in 2017 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
30% more funds holding
Funds holding: 116 → 151 (+35)
0.03% less ownership
Funds ownership: 69.01% → 68.97% (-0.03%)
32% less call options, than puts
Call options by funds: $13.5M | Put options by funds: $20M
Holders
151
Holding in Top 10
3
Calls
$13.5M
Puts
$20M
Top Buyers
| 1 | +$17M | |
| 2 | +$15.8M | |
| 3 | +$14.5M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$13.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.79M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$7.96M | |
| 3 | -$7.35M | |
| 4 |
GAM
Greenwoods Asset Management
Grand Cayman,
Cayman Islands
|
-$4.37M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$4.17M |